Todd A Covey

US Patent:

20020009776, Jan 24, 2002

Filed:

Mar 22, 2001

Appl. No.:

09/815108

Inventors:

Christiaan Saris - Newbury Park CA, US
Sharon Mu - Thousand Oaks CA, US
Min Xia - Newbury Park CA, US
Thomas Boone - Newbury Park CA, US
Todd Covey - Moorpark CA, US

Assignee:

Amgen, Inc.

International Classification:

C12P021/02
C07K014/705
G01N033/53
C12N005/06
C07H021/04

US Classification:

435/069100, 435/007100, 435/325000, 530/350000, 536/023500, 530/388220, 435/334000

Abstract:

The present invention provides Fibroblast Growth Factor Receptor-Like (FGFR-L) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing FGFR-L polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with FGFR-L polypeptides.

US Patent:

20030087384, May 8, 2003

Filed:

Aug 28, 2002

Appl. No.:

10/229584

Inventors:

Christiaan Saris - Newbury Park CA, US
Sharon Mu - Thousand Oaks CA, US
Min Xia - Newbury Park CA, US
Thomas Boone - Newbury Park CA, US
Todd Covey - Moorpark CA, US

Assignee:

Amgen Inc. A Corporation of the State of Delaware

International Classification:

C07K014/71
C07H021/04
C12P021/02
C12N005/06

US Classification:

435/069100, 435/320100, 435/325000, 530/350000, 536/023500

Abstract:

The present invention provides Fibroblast Growth Factor Receptor-Like (FGFR-L) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing FGFR-L polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with FGFR-L polypeptides.

US Patent:

20080044859, Feb 21, 2008

Filed:

Aug 13, 2007

Appl. No.:

11/838136

Inventors:

Christiaan Saris - Newbury Park CA, US
Sharon Mu - Thousand Oaks CA, US
Min Xia - Newbury Park CA, US
Thomas Boone - Newbury Park CA, US
Todd Covey - Moorpark CA, US

Assignee:

AMGEN, INC. - Thousand Oaks CA

International Classification:

C12P 21/00
C07H 21/00
C12N 1/00
C12N 15/63
C12N 5/00

US Classification:

435071100, 435243000, 435320100, 435325000, 536023500

Abstract:

The present invention provides Fibroblast Growth Factor Receptor-Like (FGFR-L) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing FGFR-L polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with FGFR-L, polypeptides.

US Patent:

20140273089, Sep 18, 2014

Filed:

Mar 14, 2013

Appl. No.:

13/828198

Inventors:

Christiaan M. Saris - Newbury Park CA, US
Sharon X. Mu - Thousand Oaks CA, US
Min Xia - Newbury Park CA, US
Thomas Charles Boone - Newbury Park CA, US
Todd Covey - Moorpark CA, US

Assignee:

AMGEN, INC. - THOUSAND OAKS CA

International Classification:

C07K 14/71

US Classification:

435 691, 435348, 435357, 435361, 435365, 435367, 435369, 4352523, 43525231, 43525233, 43525234, 43525235, 4352542, 43525421, 43525423, 4353201, 536 235

Abstract:

The present invention provides Fibroblast Growth Factor Receptor-Like (FGFR-L) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing FGFR-L polypeptides. The inventio further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with FGFR-L polypeptides.